ATE234088T1 - Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol - Google Patents
Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxolInfo
- Publication number
- ATE234088T1 ATE234088T1 AT93922310T AT93922310T ATE234088T1 AT E234088 T1 ATE234088 T1 AT E234088T1 AT 93922310 T AT93922310 T AT 93922310T AT 93922310 T AT93922310 T AT 93922310T AT E234088 T1 ATE234088 T1 AT E234088T1
- Authority
- AT
- Austria
- Prior art keywords
- taxol
- treatment
- lymphomas
- breast cancer
- drug resistance
- Prior art date
Links
- 229930012538 Paclitaxel Natural products 0.000 title abstract 6
- 229960001592 paclitaxel Drugs 0.000 title abstract 6
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 6
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- 206010025323 Lymphomas Diseases 0.000 title abstract 2
- 230000036457 multidrug resistance Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 102000029749 Microtubule Human genes 0.000 abstract 1
- 108091022875 Microtubule Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 210000004688 microtubule Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95038092A | 1992-09-22 | 1992-09-22 | |
| PCT/US1993/008983 WO1994006422A1 (en) | 1992-09-22 | 1993-09-22 | Use of taxol for treating lymphomas and breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234088T1 true ATE234088T1 (de) | 2003-03-15 |
Family
ID=25490363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93922310T ATE234088T1 (de) | 1992-09-22 | 1993-09-22 | Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5496846A (de) |
| EP (1) | EP0661969B1 (de) |
| JP (1) | JP3020277B2 (de) |
| AT (1) | ATE234088T1 (de) |
| AU (1) | AU680441B2 (de) |
| CA (1) | CA2145190A1 (de) |
| DE (1) | DE69332758D1 (de) |
| WO (1) | WO1994006422A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
| US7307198B2 (en) | 1995-08-31 | 2007-12-11 | Roslin Institute | Ungulates produced by nuclear transfer of G1 cells |
| GB9517779D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
| GB2318792B (en) * | 1995-08-31 | 2000-06-21 | Roslin Inst | Unactivated oocytes as cytoplast recipients for nuclear transfer |
| GB9517780D0 (en) | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
| ES2248847T3 (es) | 1996-05-24 | 2006-03-16 | Angiotech Pharmaceuticals, Inc. | Composiciones y metodos para tratar o prevenir enfermedades de las vias de conduccion del cuerpo. |
| US5821263A (en) * | 1996-08-26 | 1998-10-13 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
| US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US20030157187A1 (en) * | 1996-12-02 | 2003-08-21 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing inflammatory diseases |
| US7361804B1 (en) | 1997-02-19 | 2008-04-22 | Roslin Institute (Edinburgh) | Unactivated oocytes in nuclear transfer to produce ungulates |
| JP3896435B2 (ja) * | 1997-12-17 | 2007-03-22 | アークレイ株式会社 | センサおよびセンサ集合体 |
| EP1067908B9 (de) * | 1998-04-01 | 2007-01-24 | Jagotec Ag | Taxan-mikroemulsionen |
| EP1685835A3 (de) * | 1999-04-22 | 2006-08-09 | American Bioscience, Inc. | Langzeitapplikation subtherapeutischer Mengen pharmakologischer Wirkstoffe |
| CA2369740A1 (en) * | 1999-04-22 | 2000-11-02 | American Biosciences, Inc. | Long term administration of pharmacologically active agents |
| US6294546B1 (en) | 1999-08-30 | 2001-09-25 | The Broad Of Trustees Of The Leland Stanford Junior University | Uses of diterpenoid triepoxides as an anti-proliferative agent |
| AU2001253336A1 (en) | 2000-04-10 | 2001-10-23 | Teva Pharmaceutical Industries Ltd. | Method 0f administration of paclitaxel-plasma protein formulation |
| US6410059B1 (en) * | 2000-10-20 | 2002-06-25 | Council Of Scientific And Industrial Research | Pharmaceutical composition containing cow urine distillate and an antibiotic |
| CZ294371B6 (cs) * | 2002-06-10 | 2004-12-15 | Pliva - Lachema, A. S. | Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy |
| US7482483B2 (en) | 2004-01-27 | 2009-01-27 | University Of South Florida | Growth factor-binding compounds and methods of use |
| WO2005080394A1 (en) * | 2004-02-24 | 2005-09-01 | Bioaxone Therapeutique Inc. | 4-substituted piperidine derivatives |
| US7989490B2 (en) * | 2004-06-02 | 2011-08-02 | Cordis Corporation | Injectable formulations of taxanes for cad treatment |
| US7459562B2 (en) * | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
| US20060252823A1 (en) * | 2005-05-04 | 2006-11-09 | Deck Lorraine M | Isocoumarin-based inhibitors of urokinase-type plasminogen activator |
| WO2008039482A2 (en) * | 2006-09-26 | 2008-04-03 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
| US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
| US20080227853A1 (en) * | 2007-03-13 | 2008-09-18 | Bionature E. A. Limited | Androgene membrane receptor agonist |
| US8403291B2 (en) * | 2007-06-21 | 2013-03-26 | Michael Wallace Howlett | Tube slide clamp with extending finger grips |
| FR2933405B1 (fr) * | 2008-07-03 | 2010-08-13 | Centre Nat Rech Scient | Derives ferroceniques a activite anticancereuse |
| US10106525B2 (en) | 2015-01-26 | 2018-10-23 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| US10857157B2 (en) | 2015-01-26 | 2020-12-08 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| US10149856B2 (en) | 2015-01-26 | 2018-12-11 | BioAxone BioSciences, Inc. | Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors |
| US11198680B2 (en) | 2016-12-21 | 2021-12-14 | BioAxone BioSciences, Inc. | Rho kinase inhibitor BA-1049 (R) and active metabolites thereof |
| US10537567B2 (en) | 2017-07-11 | 2020-01-21 | BioAxone BioSciences, Inc. | Kinase inhibitors for treatment of disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630454B2 (en) * | 2001-09-10 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Method and pharmaceutical composition for the treatment of cancer |
-
1993
- 1993-09-22 AU AU51357/93A patent/AU680441B2/en not_active Ceased
- 1993-09-22 JP JP6508423A patent/JP3020277B2/ja not_active Expired - Fee Related
- 1993-09-22 WO PCT/US1993/008983 patent/WO1994006422A1/en not_active Ceased
- 1993-09-22 AT AT93922310T patent/ATE234088T1/de not_active IP Right Cessation
- 1993-09-22 DE DE69332758T patent/DE69332758D1/de not_active Expired - Lifetime
- 1993-09-22 CA CA002145190A patent/CA2145190A1/en not_active Abandoned
- 1993-09-22 EP EP93922310A patent/EP0661969B1/de not_active Expired - Lifetime
-
1994
- 1994-01-06 US US08/178,463 patent/US5496846A/en not_active Ceased
-
1998
- 1998-03-05 US US09/035,702 patent/USRE40839E1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| USRE40839E1 (en) | 2009-07-07 |
| EP0661969A1 (de) | 1995-07-12 |
| DE69332758D1 (de) | 2003-04-17 |
| AU680441B2 (en) | 1997-07-31 |
| JPH08501560A (ja) | 1996-02-20 |
| EP0661969B1 (de) | 2003-03-12 |
| WO1994006422A1 (en) | 1994-03-31 |
| JP3020277B2 (ja) | 2000-03-15 |
| CA2145190A1 (en) | 1994-03-31 |
| US5496846A (en) | 1996-03-05 |
| AU5135793A (en) | 1994-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69332758D1 (de) | Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE69213814D1 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| KR900015730A (ko) | 정신장해 치료방해 | |
| DK0668763T3 (da) | Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme | |
| DE10199020I2 (de) | Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit. | |
| IL107109A0 (en) | Compounds for modifying drug resistance and pharmaceutical compositions containing the same | |
| DK1137762T3 (da) | Behandling af Pompes sygdom | |
| EP1007044A4 (de) | Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen | |
| DE69400799D1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
| DE69012261D1 (de) | Verwendung von Sertralin zur Behandlung verfrühter Ejakulation. | |
| DE3686582D1 (de) | Behandlung einer krankheit vom aids-typ. | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| IT1238825B (it) | Dispositivo per la correzione chirurgica dell'ametropia. | |
| DE59605959D1 (de) | Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände | |
| JO3446B1 (ar) | طريقة لمعالجة الأرق الأولي | |
| ATE291918T1 (de) | Kombinationstherapie zur behandlung von tumoren | |
| MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
| KR890000108A (ko) | 종양 치료용 약제학적 조성물 | |
| ATE70181T1 (de) | Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie. | |
| DE69010523D1 (de) | Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen. | |
| ATE295731T1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| ATE195876T1 (de) | Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |